AMEFX | FAASX | AMEFX / FAASX | |
Total Expense Ratio | 0.37 | 0.93 | 40% |
Annual Report Gross Expense Ratio | 0.37 | 0.93 | 40% |
Fund Existence | 17 years | 17 years | - |
Gain YTD | 14.743 | 13.798 | 107% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 138B | 7.3B | 1,892% |
Annual Yield % from dividends | 3.78 | 1.38 | 273% |
Returns for 1 year | 10.19 | 8.49 | 120% |
Returns for 3 years | 41.22 | 45.18 | 91% |
Returns for 5 years | 46.02 | 41.44 | 111% |
Returns for 10 years | 68.28 | 78.63 | 87% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETAHX | 39.57 | 0.43 | +1.10% |
Eventide Healthcare & Life Sciences A | |||
GMCUX | 17.02 | 0.17 | +1.01% |
Goldman Sachs Small/Mid Cap Equity R6 | |||
FCVIX | 20.26 | 0.20 | +1.00% |
Fidelity Advisor Small Cap Value I | |||
HFCGX | 32.81 | 0.30 | +0.92% |
Hennessy Cornerstone Growth Investor | |||
RWEBX | 66.35 | 0.41 | +0.62% |
American Funds Washington Mutual R2E |